B2M and diffuse large B-cell lymphoma: Pooled analysis results showed that higher β2M levels in DLBCL patients were associated with worse prognosis and lower OS (HR Pooled: 1.65, 95% CI: 1.45–1.88, p‐value < 0.01) (Figure 2).